Torrance, CA 的 心血管疾病 臨床試驗
7 項針對 心血管疾病 的研究正在 Torrance（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
招募中4 期
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
招募中3 期
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Torrance
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Torrance
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Torrance
其他城市的 心血管疾病 試驗
- Boston, MA37 項研究
- New York City, NY33 項研究
- Washington, DC28 項研究
- Houston, TX24 項研究
- Dallas, TX23 項研究
- Atlanta, GA22 項研究
- Cleveland, OH22 項研究
- Chicago, IL21 項研究
- Philadelphia, PA21 項研究
- Pittsburgh, PA20 項研究
- St. Louis, MO20 項研究
- Nashville, TN18 項研究
Torrance 的其他研究
- 非小細胞肺癌11 項研究
- 乳癌9 項研究
- 過重9 項研究
- 肥胖症9 項研究
- 肺癌7 項研究
- 膀胱癌7 項研究
- 精神分裂症6 項研究
- 心臟衰竭5 項研究
- 動脈硬化5 項研究
- 轉移性癌症4 項研究
- 大腸直腸癌4 項研究
- 冠狀動脈疾病4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。